This map shows the geographic impact of F Lacour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Lacour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Lacour more than expected).
This network shows the impact of papers produced by F Lacour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Lacour. The network helps show where F Lacour may publish in the future.
Co-authorship network of co-authors of F Lacour
This figure shows the co-authorship network connecting the top 25 collaborators of F Lacour.
A scholar is included among the top collaborators of F Lacour based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with F Lacour. F Lacour is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
20 of 20 papers shown
1.
Haguenau, F, et al.. (2003). [Ultrastructure of Murray-Begg endothelioma; problem of identification of its causal agent].. PubMed. 43(1). 10–22.
Lacour, J.‐P., F Lacour, B. Ducot, et al.. (1988). [Therapeutic trial of Poly(A).Poly(U) adjuvant immunotherapy in operable cancer of the breast. Long-term results].. PubMed. 114(6). 516–23.2 indexed citations
7.
Jl, Amiel, et al.. (1985). A phase I clinical tolerance study of polyadenylic-polyuridylic acid in cancer patients.. PubMed. 4(2). 129–33.10 indexed citations
Lacour, F, J.‐P. Lacour, Alexander I. Spira, et al.. (1980). [Adjuvant immunotherapy using polyadenylic acid and polyuridylic acid (Poly A., Poly U.) in operable carcinoma of the breast (author's transl)].. PubMed. 106(9). 737–43.3 indexed citations
Lacour, F, et al.. (1965). IDENTIFICATION IMMUNOLOGIQUE DE DIVERSES FRACTIONS DE RNA CELLULAIRE ET DE POLYNUCL'EOTIDES DE SYNTH'ESE.. Comptes rendus hebdomadaires des séances de l Académie des sciences. 260.2 indexed citations
18.
Harel, J, J Huppert, F Lacour, & L Harel. (1965). [Demonstration of a ribonucleic acid of very high molecular weight in the avian myeloblastosis virus].. PubMed. 261(11). 2266–8.5 indexed citations
19.
Huppert, J., F Lacour, J.‐P. Lacour, & J Harel. (1961). [Increase in the incidence of malignant tumors in the mouse after inoculation of ribonucleic acid].. PubMed. 252. 1876–8.1 indexed citations
20.
Harel, J, J. Huppert, F Lacour, & J.‐P. Lacour. (1958). [Induction of malignant tumors newborn mouse by injection of a preparation of ribonucleic acid extracted from human leukemic lymph node].. PubMed. 247(10). 795–6.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.